These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


219 related items for PubMed ID: 1287237

  • 1. [Chronic fatigue syndrome in school children].
    Kawa K.
    Nihon Rinsho; 1992 Nov; 50(11):2606-11. PubMed ID: 1287237
    [Abstract] [Full Text] [Related]

  • 2. The hypothalamo-pituitary-adrenal axis in chronic fatigue syndrome and fibromyalgia syndrome.
    Tanriverdi F, Karaca Z, Unluhizarci K, Kelestimur F.
    Stress; 2007 Mar; 10(1):13-25. PubMed ID: 17454963
    [Abstract] [Full Text] [Related]

  • 3. [The HPA axis in the pathogenesis of chronic fatigue syndrome].
    Ursini F, Succurro E, Grembiale A, Gagliardi DA, Arturi F.
    Clin Ter; 2010 Mar; 161(5):461-4. PubMed ID: 20949245
    [Abstract] [Full Text] [Related]

  • 4. Chronic fatigue syndrome: a stress disorder?
    Cleare AJ, Wessely SC.
    Br J Hosp Med; 2010 Mar; 55(9):571-4. PubMed ID: 8735034
    [No Abstract] [Full Text] [Related]

  • 5. The effect of brief exercise cessation on pain, fatigue, and mood symptom development in healthy, fit individuals.
    Glass JM, Lyden AK, Petzke F, Stein P, Whalen G, Ambrose K, Chrousos G, Clauw DJ.
    J Psychosom Res; 2004 Oct; 57(4):391-8. PubMed ID: 15518675
    [Abstract] [Full Text] [Related]

  • 6. Basal activity of the hypothalamic-pituitary-adrenal axis in patients with the chronic fatigue syndrome (neurasthenia).
    Young AH, Sharpe M, Clements A, Dowling B, Hawton KE, Cowen PJ.
    Biol Psychiatry; 1998 Feb 01; 43(3):236-7. PubMed ID: 9494707
    [Abstract] [Full Text] [Related]

  • 7. The HPA axis and the genesis of chronic fatigue syndrome.
    Cleare AJ.
    Trends Endocrinol Metab; 2004 Mar 01; 15(2):55-9. PubMed ID: 15036250
    [Abstract] [Full Text] [Related]

  • 8. Neuroaetiology of chronic fatigue syndrome: an overview.
    Sanders P, Korf J.
    World J Biol Psychiatry; 2008 Mar 01; 9(3):165-71. PubMed ID: 17853290
    [Abstract] [Full Text] [Related]

  • 9. The neuroendocrinology of chronic fatigue syndrome: focus on the hypothalamic-pituitary-adrenal axis.
    Scott LV, Dinan TG.
    Funct Neurol; 1999 Mar 01; 14(1):3-11. PubMed ID: 10321324
    [No Abstract] [Full Text] [Related]

  • 10. Neuroendocrine mechanisms in fibromyalgia-chronic fatigue.
    Buskila D, Press J.
    Best Pract Res Clin Rheumatol; 2001 Dec 01; 15(5):747-58. PubMed ID: 11812019
    [Abstract] [Full Text] [Related]

  • 11. 24-hour pituitary and adrenal hormone profiles in chronic fatigue syndrome.
    Di Giorgio A, Hudson M, Jerjes W, Cleare AJ.
    Psychosom Med; 2005 Dec 01; 67(3):433-40. PubMed ID: 15911907
    [Abstract] [Full Text] [Related]

  • 12. Chronic fatigue syndrome: an update.
    Komaroff AL, Buchwald DS.
    Annu Rev Med; 1998 Dec 01; 49():1-13. PubMed ID: 9509246
    [Abstract] [Full Text] [Related]

  • 13. Chronic fatigue syndrome and high allostatic load: results from a population-based case-control study in Georgia.
    Maloney EM, Boneva R, Nater UM, Reeves WC.
    Psychosom Med; 2009 Jun 01; 71(5):549-56. PubMed ID: 19414615
    [Abstract] [Full Text] [Related]

  • 14. Combined dexamethasone/corticotropin-releasing factor test in chronic fatigue syndrome.
    Van Den Eede F, Moorkens G, Hulstijn W, Van Houdenhove B, Cosyns P, Sabbe BG, Claes SJ.
    Psychol Med; 2008 Jul 01; 38(7):963-73. PubMed ID: 17803834
    [Abstract] [Full Text] [Related]

  • 15. Stress-induced changes in LPS-induced pro-inflammatory cytokine production in chronic fatigue syndrome.
    Gaab J, Rohleder N, Heitz V, Engert V, Schad T, Schürmeyer TH, Ehlert U.
    Psychoneuroendocrinology; 2005 Feb 01; 30(2):188-98. PubMed ID: 15471616
    [Abstract] [Full Text] [Related]

  • 16. Chronic fatigue syndrome: evaluation and treatment.
    Craig T, Kakumanu S.
    Am Fam Physician; 2002 Mar 15; 65(6):1083-90. PubMed ID: 11925084
    [Abstract] [Full Text] [Related]

  • 17. Associations between neuroendocrine responses to the Insulin Tolerance Test and patient characteristics in chronic fatigue syndrome.
    Gaab J, Engert V, Heitz V, Schad T, Schürmeyer TH, Ehlert U.
    J Psychosom Res; 2004 Apr 15; 56(4):419-24. PubMed ID: 15094026
    [Abstract] [Full Text] [Related]

  • 18. Chronic fatigue syndrome: an update focusing on phenomenology and pathophysiology.
    Cho HJ, Skowera A, Cleare A, Wessely S.
    Curr Opin Psychiatry; 2006 Jan 15; 19(1):67-73. PubMed ID: 16612182
    [Abstract] [Full Text] [Related]

  • 19. Normal opioid tone and hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome despite marked functional impairment.
    Inder WJ, Prickett TC, Mulder RT.
    Clin Endocrinol (Oxf); 2005 Mar 15; 62(3):343-8. PubMed ID: 15730417
    [Abstract] [Full Text] [Related]

  • 20. Glucocorticoid receptor mediated negative feedback in chronic fatigue syndrome using the low dose (0.5 mg) dexamethasone suppression test.
    Papadopoulos A, Ebrecht M, Roberts AD, Poon L, Rohleder N, Cleare AJ.
    J Affect Disord; 2009 Jan 15; 112(1-3):289-94. PubMed ID: 18573538
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.